Contact

FlyPharma is an advanced biomanufacturing platform headquartered in Hong Kong with pilot operations in Brisbane, Australia, focused on the scalable and cost-efficient production of complex biologics. The company utilizes a pioneering biological production architecture that employs genetically modified Black Soldier Fly strains as in vivo expression hosts. By integrating genetic engineering, automation, and proprietary process systems, FlyPharma enables the production of targeted proteins and bioactive compounds during larval growth. This platform is designed for industrial-scale deployment, specifically targeting high-volume animal health, aquaculture, and feed additive markets. FlyPharma aims to transform biological production into a controlled engineering process, providing a sustainable and reliable supply of feed-grade biologics while significantly reducing the capital intensity associated with traditional manufacturing methods.